Juan-gonzalo A. Correa

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

Journal: American journal of hematology

Published: June 25, 2023

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.

Journal: Leukemia

Published: July 28, 2021

Housing and accessibility after the COVID-19 pandemic: Rebuilding for resilience, equity and sustainable mobility.

Housing and accessibility after the COVID-19 pandemic: Rebuilding for resilience, equity and sustainable mobility.

Journal: Transport policy

Published: March 31, 2021

Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model.

Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: June 09, 2020

Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis.

Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis.

Journal: Medicina clinica

Published: August 30, 2019

Genomic characterization in triple-negative primary myelofibrosis and other myeloid neoplasms with bone marrow fibrosis.

Genomic characterization in triple-negative primary myelofibrosis and other myeloid neoplasms with bone marrow fibrosis.

Journal: Annals of hematology

Published: June 03, 2019

Prognostic risk models for transplant decision-making in myelofibrosis.

Prognostic risk models for transplant decision-making in myelofibrosis.

Journal: Annals of hematology

Published: August 21, 2017

Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia.

Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia.

Journal: British journal of haematology

Published: April 19, 2017

Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis.

Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis.

Journal: European journal of haematology

Published: December 19, 2016

Imatinib dose reduction in patients with chronic myeloid leukemia in sustained deep molecular response.

Imatinib dose reduction in patients with chronic myeloid leukemia in sustained deep molecular response.

Journal: Annals of hematology

Published: July 04, 2016

Alleviating anemia and thrombocytopenia in myelofibrosis patients.

Alleviating anemia and thrombocytopenia in myelofibrosis patients.

Journal: Expert review of hematology

Published: February 19, 2016

Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results.

Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results.

Journal: Annals of hematology

Published: May 20, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026